Clinical Trial Update: FB-CT2 Includes Two Prospective, Multi-centre Studies With a Medical Device in Hospital Settings: a Randomized, Dual-arm, Open-label Pilot Study in Spain, Followed by a Single-arm, Non-randomized, Open-label International Pivotal Study [NA]

View source ↗

Summary

A medical device trial program (FB-CT2) comprises two prospective, multi-centre studies for threatened preterm labor—an open-label randomized pilot in Spain fol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Threatened Preterm Labor

Snippet

Sponsor: Ultrasound-Innovation Medtech, S.L. | Conditions: Threatened Preterm Labor | NA | Status: RECRUITING